Neuromyelitis Optica Spectrum Disorders (NMOSD): Clinical Trials

1 trial for Neuromyelitis Optica Spectrum Disorders (NMOSD), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Not yet recruiting 1

Follow Neuromyelitis Optica Spectrum Disorders (NMOSD): new trials by email Literature Review of Neuromyelitis Optica Spectrum Disorders (NMOSD) trials Research Report on Neuromyelitis Optica Spectrum Disorders (NMOSD)

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Crisugabalin in NMOSD Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled Exploratory Trial
Crisugabalin, Placebo+Crisugabalin - Neuromyelitis Optica Spectrum Disorders (NMOSD), Neuropathic Pain
Phase 4Not yet recruitingTang-Du Hospital1102026-06-152026-07-13

Narrower conditions

Neuralgia (1)  ·  Neuromyelitis Optica (1)

Broader conditions

Autoimmune Diseases (1)  ·  Autoimmune Diseases of the Nervous System (1)  ·  Cranial Nerve Diseases (1)  ·  Demyelinating Autoimmune Diseases, CNS (1)  ·  Demyelinating Diseases (1)  ·  Eye Diseases (1)  ·  Immune System Diseases (1)  ·  Myelitis, Transverse (1)  ·  Nervous System Diseases (1)  ·  Neurologic Manifestations (1)  ·  Neuromuscular Diseases (1)  ·  Optic Nerve Diseases (1)  ·  Optic Neuritis (1)  ·  Pain (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Sponsors

Tang-Du Hospital (1)

Countries

China (1)

Top investigators

Jun Guo (1)